Showing 1,921 - 1,940 results of 9,650 for search 'significant ((((((gap decrease) OR (we decrease))) OR (greater decrease))) OR (mean decrease))', query time: 0.75s Refine Results
  1. 1921
  2. 1922
  3. 1923
  4. 1924

    Primers used for PCR and qRTPCR. by Huan W. Yang (19746645)

    Published 2024
    “…We found that expression of NF-κB target genes <i>TNF-α</i>, <i>IFN-γ</i>, <i>IL-6</i> and <i>IL-8</i> were modulated during the course of infection. …”
  5. 1925

    Western blots used for Fig 4C. by Huan W. Yang (19746645)

    Published 2024
    “…We found that expression of NF-κB target genes <i>TNF-α</i>, <i>IFN-γ</i>, <i>IL-6</i> and <i>IL-8</i> were modulated during the course of infection. …”
  6. 1926
  7. 1927
  8. 1928
  9. 1929

    Magnification x2 of Fig 1B. by Huan W. Yang (19746645)

    Published 2024
    “…We found that expression of NF-κB target genes <i>TNF-α</i>, <i>IFN-γ</i>, <i>IL-6</i> and <i>IL-8</i> were modulated during the course of infection. …”
  10. 1930

    Magnification X2 of Fig 4A. by Huan W. Yang (19746645)

    Published 2024
    “…We found that expression of NF-κB target genes <i>TNF-α</i>, <i>IFN-γ</i>, <i>IL-6</i> and <i>IL-8</i> were modulated during the course of infection. …”
  11. 1931
  12. 1932
  13. 1933

    Volcano plot on differential expression. by Bingshuo Shi (21485387)

    Published 2025
    “…The findings revealed that 5558 genes in total were significantly altered during diapause, with pyruvate kinase (PK), trehalose synthase (TPS), superoxide dismutase (SOD), citrate synthase (CS), and 20-hydroxyecdysone (20E) showing significant decreases. …”
  14. 1934
  15. 1935

    Summary of study eligibility criteria. by Biban Gill (1473337)

    Published 2025
    “…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.…”
  16. 1936

    Summary of study participation and feasibility. by Biban Gill (1473337)

    Published 2025
    “…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.…”
  17. 1937

    Flowchart of included and excluded patients. by P.G.J. ter Horst (21743830)

    Published 2025
    “…<div><p>Medication can affect semen quality by decreasing ejaculate volume, sperm concentration, or decreased sperm motility and sperm function in general. …”
  18. 1938

    Characteristics of the study group. by P.G.J. ter Horst (21743830)

    Published 2025
    “…<div><p>Medication can affect semen quality by decreasing ejaculate volume, sperm concentration, or decreased sperm motility and sperm function in general. …”
  19. 1939
  20. 1940